Reagents specific for all N-glycans
Award amount
$504,888Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- LECTENZ BIO, INC.
- Proposal award date
- 2017-08-01
- Contract end date
- 2020-07-31
- UEI
- JTGCK219C6F4
- Solicitation number
- PA19-029
- Topic code
- 400
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Innovative glycan-specific reagents to accelerate the detection of disease biomarkers
- Engineered Pan-Specific Reagents for N-Glycan Detection and Enrichment
- A new approach to monitoring glycosylation during glycoprotein production
- Engineered Pan-Specific Reagents for N-Glycan Detection and Enrichment
- Development of a suite of high-specificity fucose binding reagents
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Platform for Optimizing Yield and Quality of Therapeutic AAV Vector Manufacturing via Synthetic Helper Genes
- Ultra-low-temperature (6 K) static NMR-DNP for metalloproteins, proteins in cells, and materials
- Dynamical Diffraction Analysis for 3D Electron Crystallography
- Synthetic biology approaches for bio-orthogonal labeling of circular RNAs
- Break Wave lithotripsy to fragment large kidney stones
Research funding history
18 SBIR/STTR records share this UEI (2009–2025). Reported award amounts total $14,474,759. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services